Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal ...

LONDON, UK I June 02, 2025 I GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has accepted for review the NDA for ...

GAIL (India)'s Dabhol LNG Terminal in the western state of Maharashtra received its first liquefied natural gas (LNG) cargo ...

After contacting the US coast guard the 22-man crew decided to abandon ship, jumping into the lifeboat, after which they were picked up by a nearby merchant ship. With the fire still burning at the ...

Blue Origin unveils new Transporter vehicle to help humans reach Moon, which could open up travel to other planets in the ...

One newly unveiled key element is the "Transporter," a vehicle that can be launched on a single Blue Origin New Glenn rocket ...

New Zealand-based M2X teamed with MLT Transport to learn how to optimize U.S. milk transportation operations—and unlock ...

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

Virginia-based advisory firm expects growth in gasoline deliveries, bulk food products, chemicals, industrial gases, and ...

(Alliance News) - GSK PLC on Monday announced the US Food & Drug Administration has accepted for review the new drug application for its liver disease treatment, linerixibat.

New research identifies a promising strategy for correcting dopamine imbalances in the brain using a drug that blocks kappa ...